ARCHIVES

Amgen Pays $24.9 Million To Settle Kickback Charges

This article is from The Cancer Letter archive.

Vol. 39 No. 16 | April 19, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Criticized For Delays In Development Of New Drugs

January 24, 1975

BRCA Carriers Live Longer Than Those With Normal Gene

January 25, 2008

In Brief: NCAB Still Without New Appinees As Carter, Califano Delay Drags On; Keele to U. Kansas

January 19, 1979

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

FDA Approves Two Oral Drugs For Metastatic Melanoma

June 28, 2013

Carcinogenesis Program Direction Changes Near for Extramural research; Workshop Topics Listed

April 22, 1977